- Home
- ENVX vs CERT Comparison
ENVX vs CERT Comparison
Compare ENVX & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENVX
- CERT
- Stock Information
- Founded
- ENVX 2006
- CERT 2008
- Country
- ENVX United States
- CERT United States
- Employees
- ENVX N/A
- CERT N/A
- Industry
- ENVX Industrial Machinery/Components
- CERT Retail: Computer Software & Peripheral Equipment
- Sector
- ENVX Miscellaneous
- CERT Technology
- Exchange
- ENVX Nasdaq
- CERT Nasdaq
- Market Cap
- ENVX 1.6B
- CERT 1.8B
- IPO Year
- ENVX N/A
- CERT 2020
- Fundamental
- Price
- ENVX $10.77
- CERT $10.65
- Analyst Decision
- ENVX Strong Buy
- CERT Buy
- Analyst Count
- ENVX 11
- CERT 7
- Target Price
- ENVX $20.82
- CERT $15.92
- AVG Volume (30 Days)
- ENVX 7.8M
- CERT 1.1M
- Earning Date
- ENVX 02-18-2025
- CERT 02-27-2025
- Dividend Yield
- ENVX N/A
- CERT N/A
- EPS Growth
- ENVX N/A
- CERT N/A
- EPS
- ENVX N/A
- CERT N/A
- Revenue
- ENVX $20,738,000.00
- CERT $372,797,000.00
- Revenue This Year
- ENVX $195.38
- CERT $10.20
- Revenue Next Year
- ENVX $76.47
- CERT $10.01
- P/E Ratio
- ENVX N/A
- CERT N/A
- Revenue Growth
- ENVX 1429.35
- CERT 5.62
- 52 Week Low
- ENVX $5.70
- CERT $9.41
- 52 Week High
- ENVX $18.68
- CERT $19.87
- Technical
- Relative Strength Index (RSI)
- ENVX 52.00
- CERT 45.43
- Support Level
- ENVX $10.44
- CERT $10.46
- Resistance Level
- ENVX $16.20
- CERT $11.76
- Average True Range (ATR)
- ENVX 1.01
- CERT 0.47
- MACD
- ENVX -0.01
- CERT -0.02
- Stochastic Oscillator
- ENVX 23.18
- CERT 22.60
About ENVX Enovix Corporation
Enovix Corp is engaged in the business of advanced silicon-anode lithium-ion battery development and production. It is also developing its 3D cell technology and production process for the electric vehicle and energy storage markets to help enable the widespread utilization of renewable energy.
About CERT Certara Inc.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.